Breaking: A federal judge on Monday stalled major parts of health secretary Robert F. Kennedy Jr.’s campaign to remake ...
A full-year subscription to STAT is currently half off — half off! Your journalistic conscience will be full. Sounds like a ...
"Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer like that." ...
After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial financial and treatment problems, according to a new report.
Two people with paralysis were able to type using a brain-computer interface that decodes attempted finger movement, a new study showed.
An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works.
Medicare delays stall breakthrough device access, ALS carriers fear research setbacks under Trump, and more biotech news ...
Structure Therapeutics disclosed that its daily obesity pill led patients to lose about 16% of their body weight relative to placebo after 44 weeks ...
After permission to work from home was temporarily revoked in September, disabled CDC workers are still struggling to get needed accommodations, according to a letter sent to NIH Director and acting ...
Congress must pass bipartisan legislation to ensure Medicare coverage of breakthrough medical technologies, writes a physician and inventor.
Perfusion technology vastly improves organ quality in transplants, but high costs and coverage questions pose barriers in becoming the standard of care.
Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks ...